Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019719
Filing Date
2023-05-09
Accepted
2023-05-09 16:22:01
Documents
81
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eftr-20230331.htm   iXBRL 10-Q 2159880
2 EX-31.1 eftr-ex31_1.htm EX-31 20943
3 EX-31.2 eftr-ex31_2.htm EX-31 20902
4 EX-32.1 eftr-ex32_1.htm EX-32 11712
5 EX-32.2 eftr-ex32_2.htm EX-32 11677
  Complete submission text file 0000950170-23-019719.txt   10264470

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eftr-20230331.xsd EX-101.SCH 82773
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eftr-20230331_pre.xml EX-101.PRE 498567
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eftr-20230331_lab.xml EX-101.LAB 612022
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eftr-20230331_cal.xml EX-101.CAL 37809
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eftr-20230331_def.xml EX-101.DEF 357712
75 EXTRACTED XBRL INSTANCE DOCUMENT eftr-20230331_htm.xml XML 2103356
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

EIN.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39866 | Film No.: 23902405
SIC: 2834 Pharmaceutical Preparations